3-aminobenzanthrone, a human metabolite of the carcinogenic environmental pollutant 3-nitrobenzanthrone, induces biotransformation enzymes in rat kidney and lung
Language English Country Netherlands Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
19398038
DOI
10.1016/j.mrgentox.2009.04.013
PII: S1383-5718(09)00161-2
Knihovny.cz E-resources
- MeSH
- DNA Adducts * MeSH
- Benz(a)Anthracenes metabolism pharmacology MeSH
- Biotransformation MeSH
- Cytochrome P-450 CYP1A1 metabolism MeSH
- Carcinogens, Environmental metabolism MeSH
- Rats MeSH
- Kidney drug effects metabolism MeSH
- Humans MeSH
- Microsomes drug effects enzymology metabolism MeSH
- NAD(P)H Dehydrogenase (Quinone) metabolism MeSH
- Lung drug effects metabolism MeSH
- Rats, Wistar MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Humans MeSH
- Male MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- 3-aminobenzanthrone MeSH Browser
- 3-nitrobenzanthrone MeSH Browser
- DNA Adducts * MeSH
- Benz(a)Anthracenes MeSH
- Cytochrome P-450 CYP1A1 MeSH
- Carcinogens, Environmental MeSH
- NAD(P)H Dehydrogenase (Quinone) MeSH
3-aminobenzanthrone (3-ABA) is the metabolite of the carcinogenic air pollutant 3-nitrobenzanthrone (3-NBA). 3-ABA was investigated for its ability to induce cytochrome P450 1A1 (CYP1A1) and NAD(P)H:quinone oxidoreductase (NQO1) in kidney and lung of rats, and for the influence of such induction on DNA adduct formation by 3-ABA and 3-NBA. NQO1 is the enzyme that reduces 3-NBA to N-hydroxy-3-aminobenzanthrone (N-OH-3-ABA) and CYP1A enzymes oxidize 3-ABA to the same intermediate. When activated by cytosolic and and/or microsomal fractions isolated from rat lung, the target organ for 3-NBA carcinogenicity, and kidney, both compounds generated the same DNA-adduct pattern, consisting of five adducts. When pulmonary cytosols isolated from rats that had been treated i.p. with 40 mg/kg bw of 3-ABA were incubated with 3-NBA, DNA adduct formation was up to 1.7-fold higher than in incubations with cytosols from control animals. This increase corresponded to an increase in protein level and enzymatic activity of NQO1. In contrast, no induction of NQO1 expression by 3-ABA treatment was found in the kidney. Incubations of 3-ABA with renal and pulmonary microsomes of 3-ABA-treated rats led to an increase of up to a 4.5-fold in DNA-adduct formation relative to controls. The stimulation of DNA-adduct formation correlated with a higher protein expression and activity of CYP1A1 induced by 3-ABA. These results show that by inducing lung and kidney CYP1A1 and NQO1, 3-ABA increases its own enzymatic activation as well as that of the environmental pollutant, 3-NBA, thereby enhancing the genotoxic and carcinogenic potential of both compounds.
References provided by Crossref.org